Citations refer to the original publication, not to a Scieee localized version.
Martín, M., González-Rivera, M., Morales, S., De La Haba-Rodriguez, J., González-Cortijo, L., Manso, L., Albanell, J., Cruz Merino, L. D. L., & Prat, A. (2015). Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor-positive, HER2-negative, node-negative early-stage breast cancer. Taylor and Francis Group. https://doi.org/10.1185/03007995.2015.1037730
Martín, Miguel, et al. Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor-positive, HER2-negative, node-negative early-stage breast cancer. Taylor and Francis Group, 2015. https://doi.org/10.1185/03007995.2015.1037730.
Martín, Miguel, Milagros González-Rivera, Serafín Morales, Juan De La Haba-Rodriguez, Lucía González-Cortijo, Luis Manso, Joan Albanell, Luis de la Cruz Merino, and Aleix Prat. Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor-positive, HER2-negative, node-negative early-stage breast cancer. Taylor and Francis Group, 2015. https://doi.org/10.1185/03007995.2015.1037730.
Martín, M. et al. (2015) Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor-positive, HER2-negative, node-negative early-stage breast cancer. Taylor and Francis Group. Available at: https://doi.org/10.1185/03007995.2015.1037730.
M. Martín et al., “Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor-positive, HER2-negative, node-negative early-stage breast cancer,” Taylor and Francis Group, 2015, doi: 10.1185/03007995.2015.1037730.
@misc{martin2015prospective,
author = {Martín, Miguel and González-Rivera, Milagros and Morales, Serafín and De La Haba-Rodriguez, Juan and González-Cortijo, Lucía and Manso, Luis and Albanell, Joan and Cruz Merino, Luis de la and Prat, Aleix},
title = {Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor-positive, HER2-negative, node-negative early-stage breast cancer},
year = {2015},
publisher = {Taylor and Francis Group},
doi = {10.1185/03007995.2015.1037730},
url = {https://doi.org/10.1185/03007995.2015.1037730}
}
The source metadata has no journal, volume or pages. Add them from the original publication if your citation needs them.
